Myasthenia Gravis Highlights From AANEM 2023 Myasthenia Gravis Highlights From AANEM 2023

Key data on myasthenia gravis from AANEM 2023 include results on the ADAPT+ study of efgartigimod, inequities in diagnosis, and eculizumab use in pregnancy, as reviewed by Dr Nicholas Silvestri.Medscape

Source: Medscape Today Headlines - November 22, 2023 Category: Consumer Health News Tags: None ReCAP Source Type: news